Ever been told you need a stereotactic biopsy and wondered why it’s different from an ultrasound biopsy?

Stereotactic biopsies are used when breast abnormalities, such as microcalcifications, are visible only on mammography and not on ultrasound. In these cases, using 3D mammographic guidance, radiologists can precisely locate and sample these very small areas that require a higher level of accuracy.

In addition, from a technology standpoint, stereotactic biopsy is more specialized because it depends on advanced imaging systems, precise targeting mechanisms, and seamless integration between hardware and software. Moreover, the procedure often requires more time due to patient positioning, fine adjustments, and post-biopsy imaging to confirm accurate sampling.

In some cases, two separate areas need to be biopsied. As a result, each area requires its own sterile setup, equipment preparation, and precise repositioning, effectively turning one appointment into two highly controlled procedures.

As manufacturers, we design and build mammography systems with integrated stereotactic biopsy capabilities to support radiologists in performing these complex procedures with accuracy, efficiency, and confidence.

Consequently, radiologists experience a considerable uptick in performance and efficacy.

Ultimately, understanding the technology behind breast imaging helps patients and professionals alike better appreciate the precision required for early and reliable diagnosis.